|
|
.
See Category: Factors influencing health status and contact with health services
ICD-10 (CM) Code and Descriptor
|
Z42.8 |
Encounter for other plastic and reconstructive surgery following medical procedure or healed injury
|
Z428 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 83.12%
|
10.34%
|
2.64%
|
1.48%
|
0.65%
|
0.32%
|
0.42%
|
0.14%
|
0.09%
|
0.14%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z42.8*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,043
|
31,941
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,023
|
1,559
|
|
J2405
|
ONDANSETRON HCL INJECTION |
954
|
4,087
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
887
|
3,529
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
634
|
4,313
|
|
J7120
|
RINGERS LACTATE INFUSION |
519
|
663
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
486
|
3,893
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
442
|
847
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
395
|
1,076
|
|
14060
|
TIS TRNFR E/N/E/L 10 SQ CM/< |
359
|
359
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
338
|
1,435
|
|
J2001
|
LIDOCAINE INJECTION |
258
|
1,715
|
|
J1170
|
HYDROMORPHONE INJECTION |
203
|
332
|
|
15004
|
WOUND PREP F/N/HF/G |
180
|
180
|
|
J0330
|
SUCCINYCHOLINE CHLORIDE INJ |
163
|
1,038
|
|
J0131
|
INJ, ACETAMINOPHEN (NOS) |
154
|
15,251
|
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
146
|
148
|
|
15260
|
FTH/GFT FR N/E/E/L 20 SQCM/< |
144
|
144
|
|
82962
|
GLUCOSE BLOOD TEST |
135
|
168
|
|
14040
|
TIS TRNFR F/C/C/M/N/A/G/H/F |
134
|
135
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z42.8 related to the following DRG Codes:
606-607
|
